Immune checkpoint inhibitors with neoadjuvant chemoradiotherapy in proficient MMR rectal cancer: systematic review and meta-analysis
{{output}}
Background: To evaluate the efficacy and safety of neoadjuvant chemoradiotherapy plus immune checkpoint inhibitors (CRT-ICI) for mismatch repair proficient (pMMR) locally advanced rectal cancer (LARC). ... ...
